{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:56:51Z","timestamp":1793246211171,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.dmd.2026.100256","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:10:42Z","timestamp":1771978242000},"page":"100256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanism-guided untargeted-to-targeted lipidomics identifies phosphatidylcholine 38:4 in rat bile as an Abcb4\/Mdr2 inhibition marker"],"prefix":"10.1016","volume":"54","author":[{"given":"Renmeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Rabow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6835-6797","authenticated-orcid":false,"given":"Tingyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-130X","authenticated-orcid":false,"given":"Xin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiding","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenling","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-333X","authenticated-orcid":false,"given":"Yurong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2026.100256_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.dmd.2026.100256_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/954781","article-title":"Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts","volume":"2014","author":"Morita","year":"2014","journal-title":"Biomed Res Int"},{"issue":"16","key":"10.1016\/j.dmd.2026.100256_bib3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00018-008-7568-6","article-title":"Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics","volume":"65","author":"Hofmann","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"10.1016\/j.dmd.2026.100256_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1440-1746.2005.03743.x","article-title":"Progressive familial intrahepatic cholestasis: genetic disorders of biliary transporters","volume":"20","author":"Harris","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"issue":"suppl 1","key":"10.1016\/j.dmd.2026.100256_bib5","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S2210-7401(12)70018-9","article-title":"Progressive familial intrahepatic cholestasis","volume":"36","author":"Jacquemin","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100256_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3748\/wjg.14.38","article-title":"Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump","volume":"14","author":"Meier","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.dmd.2026.100256_bib7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1211","article-title":"Hy's law: predicting serious hepatotoxicity","volume":"15","author":"Temple","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.dmd.2026.100256_bib8","series-title":"U.S. Food and Drug Administration","year":"2009"},{"issue":"2","key":"10.1016\/j.dmd.2026.100256_bib39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol Sci"},{"issue":"5","key":"10.1016\/j.dmd.2026.100256_bib9","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/cpt.1222","article-title":"Can bile salt export pump inhibition testing in drug discovery and development reduce liver injury risk? An international transporter consortium perspective","volume":"104","author":"Kenna","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.dmd.2026.100256_bib10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1124\/dmd.113.054205","article-title":"Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump","volume":"42","author":"Rodrigues","year":"2014","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.dmd.2026.100256_bib11","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1124\/dmd.120.000086","article-title":"A two-tiered in vitro approach to de-risk drug candidates for potential bile salt export pump inhibition liabilities in drug discovery","volume":"48","author":"Hafey","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100256_bib12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.taap.2017.11.007","article-title":"Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition","volume":"338","author":"Cepa","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100256_bib13","first-page":"30","article-title":"Antibiotic-induced elevations of plasma bile acids in rats independent of BSEP inhibition","volume":"157","author":"Li","year":"2017","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.dmd.2026.100256_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.dmd.2026.100256_bib15","first-page":"283","article-title":"Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment","volume":"23","author":"Stiehl","year":"1995","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.dmd.2026.100256_bib16","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1021\/acs.chemrestox.5b00201","article-title":"Inhibition of MDR3 activity in human hepatocytes by drugs associated with liver injury","volume":"28","author":"He","year":"2015","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.dmd.2026.100256_bib17","series-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]","year":"2012"},{"issue":"2","key":"10.1016\/j.dmd.2026.100256_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/mol.110.067256","article-title":"Itraconazole-induced cholestasis: involvement of the inhibition of bile canalicular phospholipid translocator MDR3\/ABCB4","volume":"79","author":"Yoshikado","year":"2011","journal-title":"Mol Pharmacol"},{"issue":"8","key":"10.1016\/j.dmd.2026.100256_bib19","doi-asserted-by":"crossref","first-page":"G670","DOI":"10.1152\/ajpgi.00334.2013","article-title":"Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice","volume":"306","author":"Cai","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100256_bib20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1124\/dmd.124.001675","article-title":"CYP7A1 gene induction via SHP-Dependent or Independent Mechanisms can increase the risk of drug-induced liver injury independently or in synergy with BSEP inhibition","volume":"52","author":"Niu","year":"2024","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2026.100256_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.dmd.2026.100256_bib22","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1194\/jlr.S120001025","article-title":"Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures","volume":"61","author":"Liebisch","year":"2020","journal-title":"J Lipid Res"},{"issue":"W1","key":"10.1016\/j.dmd.2026.100256_bib23","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.dmd.2026.100256_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/acsmeasuresciau.3c00062","article-title":"Lipid isobaric mass tagging for enhanced relative quantification of unsaturated sn-positional isomers","volume":"4","author":"Yang","year":"2024","journal-title":"ACS Meas Sci Au"},{"issue":"39","key":"10.1016\/j.dmd.2026.100256_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202207098","article-title":"Lipid mass tags via aziridination for probing unsaturated lipid isomers and accurate relative quantification","volume":"61","author":"Yang","year":"2022","journal-title":"Angew Chem Int Ed Engl"},{"issue":"16","key":"10.1016\/j.dmd.2026.100256_bib26","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/cells11162516","article-title":"p73\u03b11, an isoform of the p73 tumor suppressor, modulates lipid metabolism and cancer cell growth via stearoyl-CoA desaturase-1","volume":"11","author":"Rabow","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.dmd.2026.100256_bib27","doi-asserted-by":"crossref","first-page":"9903","DOI":"10.1038\/s41467-024-54137-w","article-title":"MS-DIAL 5 multimodal mass spectrometry data mining unveils lipidome complexities","volume":"15","author":"Takeda","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.dmd.2026.100256_bib28","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.48.5.1756-1762.2004","article-title":"Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect","volume":"48","author":"Shin","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.dmd.2026.100256_bib29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","article-title":"Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)","volume":"453","author":"Oude Elferink","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.dmd.2026.100256_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115885","article-title":"Mechanism of hepatobiliary toxicity of the LPA(1) antagonist BMS-986020 developed to treat idiopathic pulmonary fibrosis: contrasts with BMS-986234 and BMS-986278","volume":"438","author":"Gill","year":"2022","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100256_bib31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.chest.2018.08.1058","article-title":"Randomized, double-blind, placebo-controlled, phase 2 trial of BMS-986020, a lysophosphatidic acid receptor antagonist for the treatment of idiopathic pulmonary fibrosis","volume":"154","author":"Palmer","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.dmd.2026.100256_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115846","article-title":"Structure dependence and species sensitivity of in vivo hepatobiliary toxicity with lysophosphatidic acid receptor 1 (LPA(1)) antagonists","volume":"438","author":"Sivaraman","year":"2022","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100256_bib33","article-title":"Genetic cholestasis: lessons from the molecular physiology of bile formation","volume":"14","author":"Jansen","year":"2000","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100256_bib34","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.3390\/ijms24054459","article-title":"A unique in vitro assay to investigate ABCB4 transport function","volume":"24","author":"Temesszentandrasi-Ambrus","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.dmd.2026.100256_bib35","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1128\/AAC.02931-15","article-title":"Inhibitory potential of antifungal drugs on ATP-binding cassette transporters P-glycoprotein, MRP1 to MRP5, BCRP, and BSEP","volume":"60","author":"Lempers","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.dmd.2026.100256_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1191\/0960327104ht479oa","article-title":"Hepatotoxicity induced by antifungal drugs itraconazole and fluconazole in rats: a comparative in vivo study","volume":"23","author":"Somchit","year":"2004","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100256_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s40001-022-00802-z","article-title":"Application of metabolomics in intrahepatic cholestasis of pregnancy: a systematic review","volume":"27","author":"Yang","year":"2022","journal-title":"Eur J Med Res"},{"issue":"23","key":"10.1016\/j.dmd.2026.100256_bib38","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1021\/acs.accounts.2c00497","article-title":"Membrane association allosterically regulates phospholipase A(2) enzymes and their specificity","volume":"55","author":"Mouchlis","year":"2022","journal-title":"Acc Chem Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T20:44:02Z","timestamp":1778186642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0090955626000255"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100256","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism-guided untargeted-to-targeted lipidomics identifies phosphatidylcholine 38:4 in rat bile as an Abcb4\/Mdr2 inhibition marker","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100256"}}